Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research How it helps Latest publication
25-hydroxycholesterol 
Potential treatment - pre-clinical evidence Natural product Antiviral Nov/25/2020
Actidione
Potential treatment - pre-clinical evidence Natural product Antiviral Nov/25/2020
Nanchangamycin
Potential treatment - pre-clinical evidence Natural product Antiviral Nov/25/2020
Callophycin A
Potential treatment - theoretical effect Natural product Antiviral Nov/21/2020
NRICM101
Potential treatment - clinical evidence Natural product Other treatment Nov/19/2020
EGYVIR
Potential treatment - pre-clinical evidence Natural product Antiviral Nov/18/2020
Boesenbergia rotunda extract
Potential treatment - pre-clinical evidence Natural product Antiviral Nov/17/2020
Panduratin A
Potential treatment - pre-clinical evidence Natural product Antiviral Nov/17/2020
Castanospermine
Potential treatment - pre-clinical evidence Natural product Antiviral Nov/16/2020
Karuquinone B
Potential treatment - theoretical effect Natural product Antiviral Nov/16/2020
Sophaline D
Potential treatment - theoretical effect Natural product Antiviral Nov/09/2020
Thalimonine
Potential treatment - theoretical effect Natural product Antiviral Nov/09/2020
Melatonin
Potential treatment - theoretical effect Natural product Antiviral Nov/06/2020
Taraxerol
Potential treatment - theoretical effect Natural product Antiviral Nov/05/2020
Withanolide A
Potential treatment - theoretical effect Natural product Antiviral Nov/05/2020
Ursolic acid
Potential treatment - theoretical effect Natural product Antiviral Nov/04/2020
Bilobetin
Potential treatment - theoretical effect Natural product Antiviral Nov/03/2020
Ginkgetin
Potential treatment - theoretical effect Natural product Antiviral Nov/03/2020
Coronil
Potential treatment - pre-clinical evidence Natural product Other treatment Nov/02/2020
Shikonin
Potential treatment - pre-clinical evidence Natural product Antiviral Oct/29/2020